NYSE · Consumer Staples
CLOROX CO /DE/ (CLX)
As-reported financials and recent SEC filings for CLOROX CO /DE/, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$7.10B
Net income
$810.0M
Net margin
11.4%
Diluted EPS
$6.52
ROE
168.0%
P/E (TTM)
15.7×
Market cap
$11.71B
Debt / equity
5.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $7.10B | $7.09B | $7.39B | $7.11B | $7.34B |
| Gross profit | $3.21B | $3.05B | $2.91B | $2.54B | $3.20B |
| Operating income | — | — | — | — | — |
| Net income | $810.0M | $280.0M | $149.0M | $462.0M | $710.0M |
| Diluted EPS | $6.52 | $2.25 | $1.20 | $3.73 | $5.58 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-06-01
View on EDGAR →8-K2026-05-28
View on EDGAR →8-K2026-05-11
View on EDGAR →424B22026-05-08
View on EDGAR →FWP2026-05-06
View on EDGAR →424B32026-05-06
View on EDGAR →42026-05-05
View on EDGAR →S-3ASR2026-05-01
View on EDGAR →Go deeper on CLX
Search CLOROX CO /DE/’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.